What is a podcast?
A podcast is an audio recording posted online — much like a radio show for your computer. It can be downloaded and listened to on your computer, iPod or any other device that plays MP3's. It can also be streamed via the web — so you can listen to it anywhere, at any time.

To learn more about podcasting and how to enjoy this exciting new feature of eMedical Dermatology Review, click here.

To listen to the Podcast, follow the links below.

Click to download the Edition here.

This saves the podcast directly on your computer's hard drive. There you can manage and play it like any song or audio file by using your music software (iTunes, Windows Media, Real Player, etc...) You can also transfer it to your iPod or MP3 player to listen to it on-the-go.

You can listen on the web here.

If you want to listen to the eMedical Dermatology Review Podcast right away, just click on the above link and it will open an internet browser and play the podcast for you via streaming media on the web. Please note: This podcast is a large file, so please be patient as the file downloads via the web. Once it's finished downloading, it will take a few more minutes for the toolbar to show. This could take a few minutes.

You can subscribe to the eMedicalDermatology Review Podcast here.

When you subscribe, you'll get new editions of the eMedical Dermatology Review Podcast automatically downloaded to your hard drive as soon as it becomes available. And just like the downloaded editions, you can manage and play it like any song or audio file by using your music software (iTunes, Windows Media, etc...) You can also transfer it to your iPod or MP3 player, Real Player, etc. to listen to it on-the-go.

CME/CNE INFORMATION        Accreditation Statement — back to top     This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.    Credit Designations — back to top     Physicians The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Nurses This 0.5 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hours.      Intended Audience — back to top     This activity has been developed for the Dermatologist, PharmD, Nurses, Dermasurgeon, Dermatopathologist, Pediatric Dermatologist, Immunodermatologist, Wound Care Specialist.      Learning Objectives — back to top     At the conclusion of this activity, participants should be able to: Discuss the possible causes of the skin barrier defect observed in subjects with Atopic Dermatitis Describe why such a barrier defect might lead to atopic dermatitis. Explain how some enzymatically-active allergens may break the skin barrier.      Internet CME/CNE Policy — back to top     The Offices of Continuing Education (CE) at The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing are committed to protect the privacy of its members and customers. The Johns Hopkins University maintains its Internet site as an information resource and service for physicians, other health professionals and the public. The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing will keep your personal and credit information confidential when you participate in a CE Internet based program. Your information will never be given to anyone outside The Johns Hopkins University. CE collects only the information necessary to provide you with the service you request.      Faculty Disclosure — back to top     It is the policy of The Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflict of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosure will be made in each newsletter. Bernard A. Cohen, MD has indicated a past and current financial relationship with Novartis, Pharmaceuticals, Astellas Pharma Inc., Medicis and Connetics. He served on the Speaker's Bureau for Novartis, Pharmaceuticals, Astellas Pharma Inc., and Medicis. He has also received grants for studies from Novartis, Pharmaceuticals and Astellas Pharma Inc. and received support for a fellowship program from Connetics. Susan Matra Rabizadeh, MD, MBA has disclosed no relationships with commercial supporters. Mark Lebwohl, MD has disclosed that he has received grants for clinical research and educational activities from, has served as an advisor, consultant and speaker to, and has served as an investigator for Abbott, Amgen, Astellas, Centecor, Genentech and Novartis. Elizabeth Sloand, PhD, CRNP, has disclosed no relationships with commercial supporters.      Unlabeled/Unapproved Uses — back to top     The author has indicated that there will not be references to unlabeled or unapproved uses of drugs, products, or procedures in this presentation.      Disclaimer Statement — back to top     The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.     © 2008 JHUSOM, IJHN, and eMedicalDermatology Review Created by DKBmed.